Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

2 thoradh

  1. SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product|vaccine
    vacsaín dhíghníomhaithe Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    inaktivierter Impfstoff | Totimpfstoff | inaktivierte Vakzine | Totvakzine
    de
    Sainmhíniú Impfstoff aus vermehrungsunfähigen Mikroorganismen.; Vakzine, die abgetoetete Bakterien oder Viren enthaelt Tagairt W'buch Immunologie; Reallex Med
    inactivated vaccine | killed vaccine | dead vaccine
    en
    Sainmhíniú vaccine created by inactivating a pathogen’s ability to replicate, but keeping it intact so that the immune system can still recognise it Tagairt "History of Vaccines. 'Different Types of Vaccines' (19.2.2021). The College of Physicians of Philadelphia"
    Nóta "Because killed or inactivated pathogens can’t replicate at all, they can’t revert to a more virulent form capable of causing disease (as with live, attenuated vaccines [ IATE:2142620/EN ]). However, they tend to provide a shorter length of protection than live vaccines, and are more likely to require boosters to create long-term immunity."
    vaccin inactivé | vaccin tué
    fr
    Sainmhíniú vaccin à base de microorganismes entiers dont l'infectivité a été détruite par la chaleur ou par traitement chimique Tagairt Biofutur, septembre 1992
  2. SOCIAL QUESTIONS|health|pharmaceutical industry
    vacsaín dhíghníomhaithe Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    gene deleted vaccine | deletion vaccine | gene-inactivated vaccine
    en
    Sainmhíniú vaccine derived from a strain in which one or more specific known virulence genes have been deleted Tagairt "COM-EN, based on:CAST Issue Paper. Vaccine Development Using Recombinant DNA Technology. Number 38. May 2008. http://www.ca.uky.edu/poultryprofitability/Production_manual/Chapter20_Issues_affecting_the_US_broiler_industry/CAST_Biotechnology_paper7.pdf [2.2.2012] & Maddox, C. W. MacNeill, A. Borst, L. Patterson, S. SAFETY AND EFFICACY OF A TRIPLE DETECTION MODIFIED LIVE VACCINE AGAINST STRANGLES http://www.reeis.usda.gov/web/crisprojectpages/217828.html [2.2.2012]"